Viani bør kun gives til kvinder, der ammer, hvis den forventede fordel af behandlingen for moderen er større end en eventuel risiko hos barnet.
Administration of Viani to women who are breastfeeding should only be considered if the expected benefit to the mother is greater than any possible risk to the child.